Baseline Characteristics of the HCC Patients analyzed in this study (n = 303).

<p>AFP, alpha-fetoprotein; AFP-L3, lens culinaris agglutinin-reactive fraction of AFP; Anti-HCVAb, anti-hepatitis C virus antibody; DCP, des-gamma-carboxy prothrombin; HBsAg, hepatitis B surface antigen.</p

Cumulative survival probability after the diagnosis of recurrence according to the mode of recurrence.

<p>Cumulative survival probability after the diagnosis of recurrence according to the mode of recurrence.</p

Univariate and Multivariate Analysis of Extrasubsegmental Recurrences (n = 303).

<p>HR, hazard ratio; CI, confidence interval; HBsAg, hepatitis B surface antigen; Anti-HCVAb, anti-hepatitis C virus antibody; AST, aspartate aminotransferase: ALT, alanine aminotransferase, AFP, alpha-fetoprotein; DCP, des-gamma-carboxy prothrombin; AFP-L3, lens culinaris agglutinin-reactive fraction of AFP.</p

Patient enrollment flow.

<p>Patient enrollment flow.</p

Univariate and Multivariate Analysis of Survival after Recurrence^*.

*<p>Clinical data at the diagnosis of recurrence were adopted.</p><p>HR, hazard ratio; CI, confidence interval; HBsAg, hepatitis B surface antigen; Anti-HCVAb, anti-hepatitis C virus antibody; AST, aspartate aminotransferase: ALT, alanine aminotransferase, AFP, alpha-fetoprotein; DCP, des-gamma-carboxy prothrombin; AFP-L3, lens culinaris agglutinin-reactive fraction of AFP.</p

The estimated hazard function over time according to the mode of recurrence.

<p>The estimated hazard function over time according to the mode of recurrence.</p

Distribution of the Original and Recurrent Tumors Divided by Subsegment.

<p>Distribution of the Original and Recurrent Tumors Divided by Subsegment.</p

Univariate and Multivariate Analysis of Intrasubsegmental Recurrences (n = 303).

<p>HR, hazard ratio; CI, confidence interval; HBsAg, hepatitis B surface antigen; Anti-HCVAb, anti-hepatitis C virus antibody; ALT, alanine aminotransferase, AFP, alpha-fetoprotein; DCP, des-gamma-carboxyprothrombin; AFP-L3, lens culinaris agglutinin-reactive fraction of AFP.</p

The smoothed plots of the estimated hazard of overall and each reactions to iodinated contrast media.

<p>The curves illustrate smoothed plot of the estimated hazard of (A) overall adverse reactions, (B) hypersensitivity, (C) physiologic and (D) other adverse reaction to iodinated contrast media in patients with no previous exposure to contrast media. The hazard function (solid line) and 95% confidence intervals (black dotted line) were estimated by a smoothing spline with three knots. Gray dotted lines show the hazard at the initial exposure.</p

The cumulative probabilities of overall and each reactions to iodinated contrast media.

<p>Graphs illustrate (A) the cumulative probability of overall adverse reactions to iodinated contrast media and (B) the cumulative probabilities of hypersensitivity, physiologic and other adverse reactions to iodinated contrast media.</p